NeurAxis Reports Third Quarter 2023 Financial Results
CARMEL, Ind., Nov. 20, 2023 -- NeurAxis, Inc. , a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults,...
Stay updated with breaking news from Neuraxis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CARMEL, Ind., Nov. 20, 2023 -- NeurAxis, Inc. , a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults,...
CARMEL, Ind., Nov. 15, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in
NeurAxis Inc. proves that a smallcap biotech can deliver best-in-market care. That's more than great news for NRXS from a revenue perspective and for its patients from a treatment point of view. It...
NeurAxis Inc. stock is in rally mode, jumping over 26% since last week. Despite this significant increase, investors following this innovative biotech anticipate further growth. That optimism is...
According to an analyst at Goldman Smallcap Research, NeurAxis Inc. shares at current levels present a compelling investment opportunity. In fact, he models for a 12-month price target of $14 a...